Rineterkib
| CAS No. | 1715025-32-3 | Cat. No. | BCP38204 |
| Name | Rineterkib | ||
| Synonyms | ERK-IN-1; ERK IN 1; ERK IN-1; ERK-IN 1; | ||
| Formula | C26H27BrF3N5O2 | M. Wt | 578.4 |
| Description | Rineterkib is a RAF and ERK1/2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC (non-small celllung cancer), BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovanan cancer. | ||
| Pathways | MAPK Pathway | ||
| Targets | MEK/ERK Raf | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.